Wolverine Trading, LLC Cytosorbents Corp Call Options Transaction History

Wolverine Trading, LLC

11 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2023 May 15, 2023	SELL	$1.79 - $4.17 $17,721 - $41,283	-9,900 Reduced 46.7%	11,300 $39,000
Q4 2022 Feb 14, 2023	SELL	$1.03 - $1.63 $2,781 - $4,401	-2,700 Reduced 11.3%	21,200 $33,000
Q3 2022 Nov 14, 2022	BUY	$1.39 - $2.46 $33,221 - $58,794	23,900 New	23,900 $32,000
Q2 2021 Aug 06, 2021	SELL	$7.55 - $9.42 $92,110 - $114,924	-12,200 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$8.23 - $11.48 $100,406 - $140,056	12,200 New	12,200 $103,000

Q3 2020 Nov 13, 2020	SELL	$7.37 - $11.54 $159,929 - $250,417	-21,700 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$6.28 - $10.59 $69,708 - $117,549	11,100 Added 104.72%	21,700 $212,000
Q4 2018 Feb 14, 2019	SELL	$7.05 - $12.64 $14,805 - $26,544	-2,100 Reduced 16.54%	10,600 $83,000
Q3 2018 Nov 14, 2018	SELL	$10.95 - $14.8 $158,775 - $214,600	-14,500 Reduced 53.31%	12,700 $164,000
Q1 2018 May 15, 2018	BUY	$6.55 - $8.2 $44,540 - $55,759	6,800 Added 33.33%	27,200 $192,000
Q3 2017 Nov 15, 2017	BUY	$4.5 - $6.2 $91,800 - $126,480	20,400	20,400 $126,000

17.8M

Ticker CTSO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 43,577,400
Market Cap $39.7M
Description
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.